MedTrace Logo

Vitamin D Intervention in Infants

NCT01723852 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2017-11-21

No results posted yet for this study

Summary

The study is a randomized, controlled, double blinded study evaluating the effect of recommended (400 IU) and 1 200 IU daily vitamin D substitution, given from 2 weeks to 2 years of age, on growth, bone development, neurologic and cognitive development, frequence of infectious diseases, allergic symptoms, and development of immunoregulation assessed at 2 years of age.

Conditions

  • Vitamin D Status

Interventions

DIETARY_SUPPLEMENT

Vitamin D at 30 ug/day

DIETARY_SUPPLEMENT

Vitamin D at 10 ug/day

Sponsors & Collaborators

  • The Finnish Governmental Special Subsidy for Health Sciences Research

    collaborator UNKNOWN

  • Päivikki and Sakari Sohlberg Foundation, Finland

    collaborator OTHER

  • The Finnish Medical Association

    collaborator OTHER

  • Helsinki University Central Hospital

    lead OTHER

Principal Investigators

  • Sture Andersson, MD, PhD · Helsinki University Central Hospital, Children's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Max Age
5 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2016-07-15
Completion
2017-11-20

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01723852 on ClinicalTrials.gov